Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Suspected viral encephalitis
Fever with confusion, new behaviour, memory loss, focal seizure, dysphasia or focal deficit may be HSV encephalitis and delay in aciclovir causes avoidable death and disability.
Action: Use ABCDE, control seizures, obtain blood and CSF when safe and start renal-adjusted intravenous aciclovir immediately. Arrange urgent MRI and EEG and continue bacterial meningitis cover when that differential remains; do not wait for imaging or PCR.
Synopsis
Recognise encephalitis from altered cognition, focal seizure and behavioural change, start intravenous aciclovir before confirmation, use MRI, EEG and repeat cerebrospinal-fluid PCR correctly, and prevent renal and neurological treatment harm.
Encephalitis means brain dysfunction with evidence of inflammation; meningism can coexist but altered cognition and focal features are decisive.
HSV-1 is the most important treatable sporadic cause in adults, often affecting temporal lobes and producing memory, language, behaviour or seizure symptoms.
Start aciclovir 10 mg/kg intravenously every 8 hours immediately, using protocol weight, hydration and renal adjustment.
Key red flags
New focal seizure, temporal-lobe symptom or personality change with fever is HSV encephalitis until urgently assessed.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.